Synergistic targeting of CDK4/6 and BCL-2 pathways in estrogen receptor positive breast cancer

被引：1
|
作者：
Whittle, J. R.
Vaillant, F.
Policheni, A. N.
Liu, K.
Pal, B.
Giner, G.
Fernandez, K.
Gray, D. H.
Caldon, C. E.
Smyth, G. K.
Visvader, J. E.
Lindeman, G. J.
机构：
[1] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Garvan Inst Med Res, Sydney, NSW, Australia
[5] Univ New South Wales, Sydney, NSW, Australia
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-PD7-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD7-07
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers
    Finn, Richard S.
    Aleshin, Alexey
    Slamon, Dennis J.
    BREAST CANCER RESEARCH, 2016, 18
  • [42] CDK4/6 inhibitors in HR-positive breast cancer immunotherapy
    Shen, Mimi
    Ma, Zhiyuan
    Zhu, Jiaxing
    Wen, Guorong
    Jin, Hai
    An, Jiaxing
    Tuo, Biguang
    Liu, Xuemei
    Li, Taolang
    BIOORGANIC CHEMISTRY, 2025, 154
  • [43] The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer
    Talia, Marianna
    Cirillo, Francesca
    Scordamaglia, Domenica
    Di Dio, Marika
    Zicarelli, Azzurra
    De Rosis, Salvatore
    Miglietta, Anna Maria
    Capalbo, Carlo
    De Francesco, Ernestina Marianna
    Belfiore, Antonino
    Grande, Fedora
    Rizzuti, Bruno
    Occhiuzzi, Maria Antonietta
    Fortino, Giancarlo
    Guzzo, Antonella
    Greco, Gianluigi
    Maggiolini, Marcello
    Lappano, Rosamaria
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [44] Clinical considerations of CDK4/6 inhibitors in HER2 positive breast cancer
    Zhang, Cui
    Zhou, Fulin
    Zou, Jiali
    Fang, Yanman
    Liu, Yuncong
    Li, Libo
    Hou, Jing
    Wang, Guanghui
    Wang, Hua
    Lai, Xiaolian
    Xie, Lu
    Jiang, Jia
    Yang, Can
    Huang, Yisidan
    Chen, Yingji
    Zhang, Hanqun
    Li, Yong
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [45] The role of targeting CDK4/6 in cancer immunotherapy
    Mengyu Sun
    Lin Dong
    Yu Wang
    Chao Liu
    Jiang Du
    Bo Wang
    Bofan Xing
    Xiaofeng Yao
    Yu Ren
    Xuan Zhou
    Holistic Integrative Oncology, 3 (1):
  • [46] Differential metabolic response of triple-negative and estrogen receptor-positive breast cancer cells to abemaciclib, a CDK4/6 inhibitor
    Jiang, Jun
    Bao, Xun
    Jiang, Yuanyuan
    Yue, Yang
    Huettemann, Maik
    Li, Jing
    CANCER RESEARCH, 2024, 84 (06)
  • [47] Metabolic alterations in Estrogen Receptorpositive breast cancer contributing to CDK4/6 resistance
    Allam, Mayar
    Coskun, Ahmet
    Hu, Thomas
    Gu, Yuan
    Badve, Sunil
    Gokmen-Polar, Yesim
    CANCER RESEARCH, 2024, 84 (09)
  • [48] Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
    Glaviano, Antonino
    Wander, Seth A.
    Baird, Richard D.
    Yap, Kenneth C. -H.
    Lam, Hiu Yan
    Toi, Masakazu
    Carbone, Daniela
    Geoerger, Birgit
    Serra, Violeta
    Jones, Robert H.
    Ngeow, Joanne
    Toska, Eneda
    Stebbing, Justin
    Crasta, Karen
    Finn, Richard S.
    Diana, Patrizia
    Vuina, Karla
    de Bruin, Robertus A. M.
    Surana, Uttam
    Bardia, Aditya
    Kumar, Alan Prem
    DRUG RESISTANCE UPDATES, 2024, 76
  • [49] Inhibition of CDK7 overcomes resistance to CDK4/6 inhibitors in hormone receptor positive breast cancer cells
    Guarducci, C.
    Nardone, A.
    Feiglin, A.
    Migliaccio, I.
    Malorni, L.
    Bonechi, M.
    Benelli, M.
    Di Leo, A.
    Hodgson, G.
    Shapiro, G.
    Brown, M.
    Jeselsohn, R.
    CANCER RESEARCH, 2019, 79 (04)
  • [50] Biomarkers of response to CDK4/6 inhibitor (CDK4/6i) in hormone receptor (HR) positive and HER2-positive breast cancer (BC) patient-derived xenografts (PDX)
    Palafox, Marta
    Herrera-Abreu, Maria Teresa
    Bellet, Meritxell
    Oliveira, Mafalda
    Bruna, Alejandra
    Rodriguez, Olga
    Guzman, Marta
    Grueso, Judit
    Vilaplana, Cristina
    Arribas, Joaquin
    di Tomaso, Emmanuelle
    Su, Faye
    Caldas, Carlos
    Turner, Nicholas C.
    Dienstmann, Rodrigo
    Baselga, Jose
    Scaltriti, Maurizio
    Cortes, Javier
    Saura, Cristina
    Serra, Violeta
    CANCER RESEARCH, 2018, 78 (13)
12345